Literature DB >> 9462243

Expression of intestinal trefoil factor mRNA is downregulated during progression of colorectal carcinomas.

H Uchino1, H Kataoka, H Itoh, M Koono.   

Abstract

AIMS: Intestinal trefoil factor is a mucosa associated trefoil peptide expressed predominantly in the goblet cells of the small and large intestine. The aim of this work was to investigate the expression of the intestinal trefoil factor gene in human colorectal cancers.
METHODS: The expression of intestinal trefoil factor mRNA was examined by northern blot analysis in 27 cases of surgically resected primary colorectal carcinoma of various stages.
RESULTS: Although intestinal trefoil factor mRNA was expressed consistently in the tumours, the levels of expression varied considerably among the cases examined. The levels of expression were low in advanced stage tumours (Dukes's B, C, and D) compared with early stage tumours (Dukes's A) (p < 0.05). In addition, there was a tendency towards a positive correlation, albeit not well defined, between the amounts of intestinal trefoil factor mRNA and the histological differentiation of tumours.
CONCLUSIONS: Intestinal trefoil factor mRNA was expressed consistently in the cases of colorectal carcinoma studied and expression was inversely associated with tumour progression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9462243      PMCID: PMC500318          DOI: 10.1136/jcp.50.11.932

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family.

Authors:  S Suemori; K Lynch-Devaney; D K Podolsky
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

2.  hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus.

Authors:  F Hauser; R Poulsom; R Chinery; L A Rogers; A M Hanby; N A Wright; W Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

3.  Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein.

Authors:  H Kindon; C Pothoulakis; L Thim; K Lynch-Devaney; D K Podolsky
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

4.  Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.

Authors:  H Mashimo; D C Wu; D K Podolsky; M C Fishman
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

5.  cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis.

Authors:  H Itoh; M Tomita; H Uchino; T Kobayashi; H Kataoka; R Sekiya; Y Nawa
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

6.  Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion.

Authors:  D K Podolsky; K Lynch-Devaney; J L Stow; P Oates; B Murgue; M DeBeaumont; B E Sands; Y R Mahida
Journal:  J Biol Chem       Date:  1993-03-25       Impact factor: 5.157

7.  Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.

Authors:  A Dignass; K Lynch-Devaney; H Kindon; L Thim; D K Podolsky
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

8.  Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes.

Authors:  M Tomita; H Itoh; N Ishikawa; A Higa; H Ide; Y Murakumo; H Maruyama; Y Koga; Y Nawa
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

9.  Conserved expression of intestinal trefoil factor in the human colonic adenoma-carcinoma sequence.

Authors:  D Taupin; K Ooi; N Yeomans; A Giraud
Journal:  Lab Invest       Date:  1996-07       Impact factor: 5.662

10.  Expression of the pNR-2/pS2 protein in diverse human epithelial tumours.

Authors:  J A Henry; M K Bennett; N H Piggott; D L Levett; F E May; B R Westley
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

  10 in total
  6 in total

1.  Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma.

Authors:  Thaer Khoury; Krishdeep Chadha; Milind Javle; Kathleen Donohue; Charles Levea; Renuka Iyer; Haruhiko Okada; Hiroki Nagase; Dongfeng Tan
Journal:  Int J Gastrointest Cancer       Date:  2005

2.  Trefoil factor family-3 is associated with aggressive behavior of colon cancer cells.

Authors:  Xianyang Yio; Jie-yu Zhang; Mark Babyatsky; Anli Chen; Jing Lin; Qui-Xiang Fan; J Lawrence Werther; Steven Itzkowitz
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.

Authors:  Akram Yusup; Bailikezi Huji; Cheng Fang; Fei Wang; Tuerxunjiang Dadihan; Hai-Jiang Wang; Halmurat Upur
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

4.  Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas.

Authors:  Haruhiko Okada; Makoto T Kimura; Dongfeng Tan; Kyoko Fujiwara; Jun Igarashi; Masatoshi Makuuchi; Ai-Min Hui; Masahiko Tsurumaru; Hiroki Nagase
Journal:  Int J Oncol       Date:  2005-02       Impact factor: 5.650

5.  Trefoil factor-3 expression in human colon cancer liver metastasis.

Authors:  Mark Babyatsky; Jing Lin; Xianyang Yio; Anli Chen; Jie-yu Zhang; Yan Zheng; Christina Twyman; Xiuliang Bao; Myron Schwartz; Swan Thung; J Lawrence Werther; Steven Itzkowitz
Journal:  Clin Exp Metastasis       Date:  2008-11-02       Impact factor: 5.150

6.  Pharmacological Inhibition of TFF3 Enhances Sensitivity of CMS4 Colorectal Carcinoma to 5-Fluorouracil through Inhibition of p44/42 MAPK.

Authors:  Ru-Mei Chen; Yi-Shiou Chiou; Qing-Yun Chong; Han-Ming Poh; Tuan-Zea Tan; Meng-Yi Zhang; Lan Ma; Tao Zhu; Vijay Pandey; Alan Prem Kumar; Peter E Lobie
Journal:  Int J Mol Sci       Date:  2019-12-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.